MedPath

Recurrent Urinary tract infection (rUTI)

Not yet recruiting
Conditions
Urinary tract infection, site notspecified,
Registration Number
CTRI/2022/09/045671
Lead Sponsor
PG Dept of Moalejat General Medicine
Brief Summary

In Recurrent Urinary tract infection (Rutis) usual prophylactic antibiotics regimens donot change the long term risk of occurrence.the aim of the study is to evaluate the efficacy of unani medicines in Rutis.In this Randomised Single arm study with a sample size of 40 patients and 6 weeks of treatment with some inclusion and exclusion criteria( mentioned in part 6).

The study will be conducted.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

1.Recurrent uti with positive urine culture, 2.Patients with symptoms as follows a.Burning micturition b.Urgency, c.frequency of micturition d.Haematuria(Benign) e.Lower abdominal pain/supra pubic pain f.Fever with chills and rigor g.Nausea and vomitings 3.Patients with renal calculi.

Exclusion Criteria

1.Complicated UTI 2.Patients with pregnancy 3.Patients with BPH 4.Chronic infections like TB; Gonorrhea; Syphills 5.Diabetes Mellitus 6.Patients with congenital abnormalities like polycystic kidney; renal agenesis; renal hypoplasia ; uretrovesical junction obstruction.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depends on before and after treatment.Cure of the disease,relief in symptoms
Treatment will be given for the duration of 6 weeksCure of the disease,relief in symptoms
Secondary Outcome Measures
NameTimeMethod
Depends on before and after treatment1.Changes in urine culture and sensitivity i.e negative culture 2.Cure of the disease, relief in symptoms

Trial Locations

Locations (1)

Govt NizamiaTibbi College and General Hospital

🇮🇳

Hyderabad, TELANGANA, India

Govt NizamiaTibbi College and General Hospital
🇮🇳Hyderabad, TELANGANA, India
Dr Qudsiya Aaftab
Principal investigator
8801008577
aaftabqudsiya@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.